Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2000;87:540-542

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vasa, M.
Right arrow Articles by Dimmeler, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vasa, M.
Right arrow Articles by Dimmeler, S.
(Circulation Research. 2000;87:540.)
© 2000 American Heart Association, Inc.


Reports

Nitric Oxide Activates Telomerase and Delays Endothelial Cell Senescence

Mariuca Vasa, Kristin Breitschopf, Andreas M. Zeiher, Stefanie Dimmeler

From Molecular Cardiology, Department of Internal Medicine IV, University of Frankfurt, Germany.

Correspondence to Stefanie Dimmeler, PhD, Molecular Cardiology, University of Frankfurt, Theodor Stern-Kai 7, 60590 Frankfurt, Germany. E-mail Dimmeler{at}em.uni-frankfurt.de


Key Words: nitric oxide • aging • endothelial cells • telomerase


*    Introduction
up arrowTop
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Endothelial cells (ECs) undergo a limited number of cell divisions, ultimately stop dividing, and enter a state that is designated replicative senescence. Shortening of telomeres is believed to be a molecular clock that triggers senescence. Telomerase, a RNA-directed DNA polymerase, extends telomeres of eukaryotic chromosomes and delays the development of senescence. In this study, we examined telomere length and the activity of telomerase during aging of human ECs in culture and elucidated the effect of nitric oxide (NO). A significant increase in senescent cells as detected by acidic ß-galactosidase expression and a reduction of telomere length were found after 11 passages. Telomerase activity was reduced after the seventh passage, thereby preceding the development of EC senescence. The repeated addition of the NO donor S-nitroso-penicillamine significantly reduced EC senescence and delayed age-dependent inhibition of telomerase activity, whereas inhibition of endogenous NO synthesis had an adverse effect. Taken together, our results demonstrate that telomerase inactivation precedes EC aging. NO prevents age-related downregulation of telomerase activity and delays EC senescence.

The incidence of atherosclerosis increases with age. Aging is associated not only with endothelial dysfunction, a key pathogenic factor in atherosclerotic disease progression,1 2 but also impairs angiogenesis,3 suggesting that the process of aging itself affects endothelial cell (EC) function.

On a cellular level, aging leads to an irreversible state of cell cycle arrest known as replicative senescence.4 It is generally believed that a relevant factor in regulating cellular life span is the telomere length.5 Telomerase, a ribonucleoprotein with reverse transcriptase activity, synthesizes the telomeric repeats at the linear ends of eukaryotic chromosomes.5 Telomerase is active in germline cells and cancer cells, whereas it is repressed in most somatic cells, resulting in the progressive telomere shortening with each cell division.6

A recent study demonstrated that homocysteine, a proatherosclerotic factor, accelerates the rate of EC senescence in vitro, suggesting an association between EC senescence and atherosclerosis.7 Importantly, EC nitric oxide (NO) bioavailability, a pivotal atheroprotective mechanism, decreases as a function of age.8 Therefore, we investigated the role of telomerase activity for EC senescence and the potential effects of NO on the age-related changes in telomerase activity.


*    Materials and Methods
up arrowTop
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Cell Culture
Human umbilical vein endothelial cells (HUVECs) were obtained from Cell Systems/Clonetics and cultivated as previously described.9

Acidic ß-Galactosidase (ß-Gal) Staining
Cells were fixed and incubated for 12 hours at 37°C with ß-Gal staining solution.10

Telomerase Assay
HUVECs were washed in PBS and lysed, and telomerase activity was measured by the Telo TAGGG Telomerase PCR ELISAPLUS kit (Roche Molecular Biochemicals). Alternatively, the telomerase products were separated on an acrylamide gel (12%) and detected with the Biotin Luminescent Detection kit (Roche Molecular Biochemicals).

Telomere Length Assay
Genomic DNA was isolated, and 4 µg was digested overnight at 37°C with HinfI/RsaI. The resulting DNA fragments were separated onto a 0.7% agarose gel, blotted, and hybridized with radioactively labeled oligonucleotides (5'-CCCTAA-3')4 at 50°C for 8 hours. The products were detected by phosphoimaging.

An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org.


*    Results
up arrowTop
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Prolonged passage of ECs leads to the induction of acidic ß-Gal as a marker protein for senescence with maximal effects observed at passage 14 (Figures 1ADown and 1BDown). Light microscopy confirmed the typical features of replicative senescence including an increased cell size and cytoplasmic granularity (Figure 1BDown). Moreover, ultrastructural analysis revealed convoluted nuclei and vacuolization of cytoplasm (Figure 1Down online, available in an online-only data supplement at http://www.circresaha.org). At passage 14, senescent ECs still express the EC marker protein von Willebrand factor (Figure 1CDown), whereas increasing passages lead to a loss of von Willebrand factor expression indicating a dedifferentiation of ECs (data not shown). Control experiments confirmed that no increase in apoptosis occurred during the observation period (data not shown).



View larger version (37K):
[in this window]
[in a new window]
 
Figure 1. Senescence, telomere length, and telomerase activity in aging HUVECs. A and B, HUVECs were continuously passaged, and acidic ß-Gal staining and telomerase activity were determined, n=4. B, Representative figure. C, Detection of von Willebrand factor with FITC-linked antibodies. Cells were counterstained with DAPI. Representative result is shown. D, Reduction of telomere length in HUVECs during aging by Southern blot analysis. Representative result is shown (n=3).

Senescence is believed to be triggered by a critical shortening of telomere length. EC senescence correlated with a shortening of telomere length (Figure 1DUp). Because telomerase antagonizes telomere loss, we analyzed telomerase activity in ECs. HUVECs revealed a significant telomerase activity during early passages, which decreased with increasing passages (Figure 1AUp). Importantly, the reduction of telomerase activity clearly preceded the onset of EC senescence (Figure 1AUp).

To examine the effects of NO on the onset of EC senescence, HUVECs were incubated with the NO donor S-nitrosopenicillamine (SNAP), which was added every 48 hours. Figure 2ADown illustrates that the addition of SNAP significantly reduced the number of senescent ß-Gal–positive cells with maximal effect after 30 population doublings (53±7% reduction, P<0.05). To exclude a potential influence of NO on cell-cycle progression, the data are expressed as a function of population doublings. For comparison, the data plotted against the passage numbers are shown in the online data supplement (Figure 2Down online, available in an online-only data supplement at http://www.circresaha.org). Importantly, inhibition of EC senescence was accompanied by a significant delay in the inactivation of telomerase activity and the shortening of telomere length during continuous passages of the cells (Figures 2BDown and 2CDown; data not shown). Moreover, we analyzed the effect of short-term exposure to different NO donors for 18 hours. In both HUVECs (fourth passage) starved for 12 hours in 1% BSA and ECs at passage 11 or 13 in complete medium, incubation with the NO donors was associated with a significant increase in telomerase activity (Figure 2DDown; data not shown). Furthermore, inhibition of endogenous NO synthesis by NG-mono-methyl-L-arginine induced a 2-fold increase in EC senescence and reduced telomerase activity (Figure 2BDown).



View larger version (35K):
[in this window]
[in a new window]
 
Figure 2. Effect of NO on senescence and telomerase activity. A, SNAP (20 µmol/L) was added every 48 hours starting at the eighth passage, and HUVEC senescence was detected by acidic ß-Gal staining (A). NG-mono-methyl-L-arginine (LNMA, 1 mmol/L) was added every 12 hours starting at the sixth passage. Telomerase activity was detected by ELISA (percentage compared with samples at population doubling 14; *P<0.05 vs control) (B) or by separation of telomerase-synthesized DNA ladders (C). Representative figures are shown (n=4 to 6). D, Short-term effect of SNAP (50 µmol/L), sodium nitroprusside (SNP, 50 µmol/L), or S-nitrosoglutathione (GSNO, 20 µmol/L) on telomerase activity. HUVECs (fourth passage) were starved for 12 hours in medium containing 1% BSA before incubation with the NO donors for 18 hours. Telomerase activity was detected by ELISA (n=4 to 6).


*    Discussion
up arrowTop
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
The results of the present study suggest a link between reduced telomerase activity and senescence of ECs in culture. A reduction in telomerase activity invariably preceded EC senescence, suggesting that downregulation of telomerase activity may be involved in the progression of senescence. These data are in line with findings showing that stable overexpression of telomerase prevents EC senescence.11 The function of endogenous telomerase in somatic cells is not clear. Telomerase activity is thought to be repressed in normal somatic cells, whereas it is upregulated in embryogenesis and neoplasia.6 Our present data demonstrate that telomerase is active in HUVECs and in iliac and microvascular ECs (data not shown), thus complementing previous studies demonstrating low telomerase activity in several proliferating somatic cells including primary ECs.12 13

Importantly, exogenous NO delays EC senescence in culture, suggesting that shortening of telomeres is not strictly a function of the number of cellular divisions but can be modulated. Indeed, NO interferes with telomerase activity thereby inhibiting telomere shortening. The mechanism by which NO stimulates telomerase activity remains to be determined. NO may react with tissue-derived oxygen radicals, thereby reducing oxidative stress, which has been shown to accelerate EC senescence.7 Alternatively, NO may directly upregulate telomerase activity via transcriptional and/or posttranscriptional mechanisms.

Regardless of the molecular mechanisms involved in the modulation of telomerase activity, the demonstration that NO affects telomerase activity and delays EC senescence establishes a novel endothelial protective function of NO. The integrity of EC function including the capability of ECs to proliferate and migrate is essential for angiogenesis.14 Therefore, EC senescence and the consequent reduction of their proliferative ability may contribute to compromised angiogenesis associated with advanced age.3 Additionally, senescent ECs express adhesion molecules, which may promote neutrophil adhesion and inflammation.7 Thus, EC senescence may also enhance the chronic inflammatory process, which importantly contributes to the progression of atherosclerotic disease.15

On the other hand, endothelial NO is essential for angiogenesis and protects against atherosclerosis.16 17 However, the bioavailability of endothelial-derived NO is impaired with aging.8 18 Therefore, it is tempting to speculate that the reduction of NO may accelerate EC senescence, thereby impairing EC function and contributing to impaired angiogenesis and atherosclerotic disease progression in advanced age.


*    Acknowledgments
 
This work was supported by the Deutsche Forschungsgemeinschaft (SFB553) and by a grant for young research scientists to K.B. by the University of Frankfurt. We would like to thank Alexandra Bittner for expert technical assistance and Prof Wolfgang Schlote (Edinger Institut, Frankfurt) and Barbara Lafferton for help with the electron microscopy.

Received July 20, 2000; revision received August 15, 2000; accepted August 23, 2000.


*    References
up arrowTop
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest. 1993;92:652–662.

2. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899–1906.[Abstract/Free Full Text]

3. Rivard A, Fabre JE, Silver M, Chen D, Murohara T, Kearney M, Magner M, Asahara T, Isner JM. Age-dependent impairment of angiogenesis. Circulation. 1999;99:111–120.[Abstract/Free Full Text]

4. Goldstein S. Replicative senescence: the human fibroblast comes of age. Science. 1990;249:1129–1133.[Abstract/Free Full Text]

5. Buys CH. Telomeres, telomerase, and cancer. N Engl J Med. 2000;342:1282–1283.[Free Full Text]

6. Liu JP. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J. 1999;13:2091–2104.[Abstract/Free Full Text]

7. Xu D, Neville R, Finkel T. Homocysteine accelerates endothelial cell senescence. FEBS Lett. 2000;470:20–24.[Medline] [Order article via Infotrieve]

8. Tschudi MR, Barton M, Bersinger NA, Moreau P, Cosentino F, Noll G, Malinski T, Luscher TF. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest. 1996;98:899–905.[Medline] [Order article via Infotrieve]

9. Dimmeler S, Assmus B, Hermann C, Haendeler J, Zeiher AM. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circ Res. 1998;83:334–342.[Abstract/Free Full Text]

10. van der Loo B, Fenton MJ, Erusalimsky JD. Cytochemical detection of a senescence-associated ß-galactosidase in endothelial and smooth muscle cells from human and rabbit blood vessels. Exp Cell Res. 1998;241:309–315.[Medline] [Order article via Infotrieve]

11. Yang J, Chang E, Cherry AM, Bangs CD, Oei Y, Bodnar A, Bronstein A, Chiu CP, Herron GS. Human endothelial cell life extension by telomerase expression. J Biol Chem. 1999;274:26141–26148.[Abstract/Free Full Text]

12. Ramakrishnan S, Eppenberger U, Mueller H, Shinkai Y, Narayanan R. Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res. 1998;58:622–625.[Abstract/Free Full Text]

13. Hsiao R, Sharma HW, Ramakrishnan S, Keith E, Narayanan R. Telomerase activity in normal human endothelial cells. Anticancer Res. 1997;17:827–832.[Medline] [Order article via Infotrieve]

14. Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest. 1999;103:1231–1236.[Medline] [Order article via Infotrieve]

15. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol. 1995;57:791–804.[Medline] [Order article via Infotrieve]

16. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, Isner JM. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101:2567–2578.[Medline] [Order article via Infotrieve]

17. Moroi M, Zhang L, Yasuda T, Virmani R, Gold HK, Fishman MC, Huang PL. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular responses to injury in mice. J Clin Invest. 1998;101:1225–1232.[Medline] [Order article via Infotrieve]

18. Chauhan A, More RS, Mullins PA, Taylor G, Petch C, Schofield PM. Aging-associated endothelial dysfunction in humans is reversed by L-arginine. J Am Coll Cardiol. 1996;28:1796–1804.[Abstract]




This article has been cited by other articles:


Home page
Ther Adv Cardiovasc DisHome page
T. Imanishi, H. Tsujioka, and T. Akasaka
Endothelial progenitor cell senescence is there a role for estrogen?
Therapeutic Advances in Cardiovascular Disease, February 1, 2010; 4(1): 55 - 69.
[Abstract] [PDF]


Home page
CirculationHome page
R. Menghini, V. Casagrande, M. Cardellini, E. Martelli, A. Terrinoni, F. Amati, M. Vasa-Nicotera, A. Ippoliti, G. Novelli, G. Melino, et al.
MicroRNA 217 Modulates Endothelial Cell Senescence via Silent Information Regulator 1
Circulation, October 13, 2009; 120(15): 1524 - 1532.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
J. D. Erusalimsky and C. Skene
Mechanisms of endothelial senescence
Exp Physiol, March 1, 2009; 94(3): 299 - 304.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Oeseburg, D. Iusuf, P. van der Harst, W. H. van Gilst, R. H. Henning, and A. J.M. Roks
Bradykinin Protects Against Oxidative Stress-Induced Endothelial Cell Senescence
Hypertension, February 1, 2009; 53(2): 417 - 422.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Farsetti, A. Grasselli, S. Bacchetti, C. Gaetano, and M. C. Capogrossi
The telomerase tale in vascular aging: regulation by estrogens and nitric oxide signaling
J Appl Physiol, January 1, 2009; 106(1): 333 - 337.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. D. Erusalimsky
Vascular endothelial senescence: from mechanisms to pathophysiology
J Appl Physiol, January 1, 2009; 106(1): 326 - 332.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Jakob, P. Schroeder, M. Lukosz, N. Buchner, I. Spyridopoulos, J. Altschmied, and J. Haendeler
Nuclear Protein Tyrosine Phosphatase Shp-2 Is One Important Negative Regulator of Nuclear Export of Telomerase Reverse Transcriptase
J. Biol. Chem., November 28, 2008; 283(48): 33155 - 33161.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Ota, M. Eto, M. R. Kano, S. Ogawa, K. Iijima, M. Akishita, and Y. Ouchi
Cilostazol Inhibits Oxidative Stress-Induced Premature Senescence Via Upregulation of Sirt1 in Human Endothelial Cells
Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1634 - 1639.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. Zeng and Q. Xu
eNOS-ER{alpha} Complex Goes to Telomerase
Circ. Res., July 3, 2008; 103(1): 10 - 12.
[Full Text] [PDF]


Home page
Circ. Res.Home page
A. Grasselli, S. Nanni, C. Colussi, A. Aiello, V. Benvenuti, G. Ragone, F. Moretti, A. Sacchi, S. Bacchetti, C. Gaetano, et al.
Estrogen Receptor-{alpha} and Endothelial Nitric Oxide Synthase Nuclear Complex Regulates Transcription of Human Telomerase
Circ. Res., July 3, 2008; 103(1): 34 - 42.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Scalera, J. Martens-Lobenhoffer, A. Bukowska, U. Lendeckel, M. Tager, and S. M. Bode-Boger
Effect of Telmisartan on Nitric Oxide-Asymmetrical Dimethylarginine System: Role of Angiotensin II Type 1 Receptor and Peroxisome Proliferator Activated Receptor {gamma} Signaling During Endothelial Aging
Hypertension, March 1, 2008; 51(3): 696 - 703.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Minamino and I. Komuro
Vascular Cell Senescence: Contribution to Atherosclerosis
Circ. Res., January 5, 2007; 100(1): 15 - 26.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. J. Fuster and V. Andres
Telomere Biology and Cardiovascular Disease
Circ. Res., November 24, 2006; 99(11): 1167 - 1180.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Doshida, M. Ohmichi, S. Tsutsumi, J. Kawagoe, T. Takahashi, B. Du, A. Mori-Abe, T. Ohta, M. Saitoh-Sekiguchi, K. Takahashi, et al.
Raloxifene Increases Proliferation and Up-regulates Telomerase Activity in Human Umbilical Vein Endothelial Cells
J. Biol. Chem., August 25, 2006; 281(34): 24270 - 24278.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Yokoi, K. Fukuo, O. Yasuda, M. Hotta, J. Miyazaki, Y. Takemura, H. Kawamoto, H. Ichijo, and T. Ogihara
Apoptosis Signal-Regulating Kinase 1 Mediates Cellular Senescence Induced by High Glucose in Endothelial Cells
Diabetes, June 1, 2006; 55(6): 1660 - 1665.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Aviv, A. Valdes, J. P. Gardner, R. Swaminathan, M. Kimura, and T. D. Spector
Menopause Modifies the Association of Leukocyte Telomere Length with Insulin Resistance and Inflammation
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 635 - 640.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
S. M Bode-Boger, F. Scalera, and J. Martens-Lobenhoffer
Asymmetric dimethylarginine (ADMA) accelerates cell senescence
Vascular Medicine, July 1, 2005; 10(1_suppl): S65 - S71.
[Abstract] [PDF]


Home page
Vasc MedHome page
S. M Bode-Boger, F. Scalera, and J. Martens-Lobenhoffer
Asymmetric dimethylarginine (ADMA) accelerates cell senescence
Vascular Medicine, May 1, 2005; 10(2_suppl): S65 - S71.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
M. D. Edo and V. Andres
Aging, telomeres, and atherosclerosis
Cardiovasc Res, May 1, 2005; 66(2): 213 - 221.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. P. Brandes, I. Fleming, and R. Busse
Endothelial aging
Cardiovasc Res, May 1, 2005; 66(2): 286 - 294.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Zaccagnini, C. Gaetano, L. Della Pietra, S. Nanni, A. Grasselli, A. Mangoni, R. Benvenuto, M. Fabrizi, S. Truffa, A. Germani, et al.
Telomerase Mediates Vascular Endothelial Growth Factor-dependent Responsiveness in a Rat Model of Hind Limb Ischemia
J. Biol. Chem., April 15, 2005; 280(15): 14790 - 14798.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Chen, A. Zacharek, C. Zhang, H. Jiang, Y. Li, C. Roberts, M. Lu, A. Kapke, and M. Chopp
Endothelial Nitric Oxide Synthase Regulates Brain-Derived Neurotrophic Factor Expression and Neurogenesis after Stroke in Mice
J. Neurosci., March 2, 2005; 25(9): 2366 - 2375.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Murga, O. Fernandez-Capetillo, and G. Tosato
Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2
Blood, March 1, 2005; 105(5): 1992 - 1999.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Pascale, G. C. Reale, and E. D'Ambrosio
Tumor Cells Fail to trans-Induce Telomerase in Human Umbilical Vein Endothelial Cell Cultures
Cancer Res., November 1, 2004; 64(21): 7702 - 7705.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Scalera, J. Borlak, B. Beckmann, J. Martens-Lobenhoffer, T. Thum, M. Tager, and S. M. Bode-Boger
Endogenous Nitric Oxide Synthesis Inhibitor Asymmetric Dimethyl L-Arginine Accelerates Endothelial Cell Senescence
Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1816 - 1822.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. Asahara and A. Kawamoto
Endothelial progenitor cells for postnatal vasculogenesis
Am J Physiol Cell Physiol, September 1, 2004; 287(3): C572 - C579.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. J. Kurz, S. Decary, Y. Hong, E. Trivier, A. Akhmedov, and J. D. Erusalimsky
Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells
J. Cell Sci., May 1, 2004; 117(11): 2417 - 2426.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Haendeler, J. Hoffmann, J. F. Diehl, M. Vasa, I. Spyridopoulos, A. M. Zeiher, and S. Dimmeler
Antioxidants Inhibit Nuclear Export of Telomerase Reverse Transcriptase and Delay Replicative Senescence of Endothelial Cells
Circ. Res., April 2, 2004; 94(6): 768 - 775.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. L. Serrano and V. Andres
Telomeres and Cardiovascular Disease: Does Size Matter?
Circ. Res., March 19, 2004; 94(5): 575 - 584.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
A. Csiszar, Z. Ungvari, A. Koller, J. G. Edwards, and G. Kaley
Proinflammatory phenotype of coronary arteries promotes endothelial apoptosis in aging
Physiol Genomics, March 12, 2004; 17(1): 21 - 30.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. J. Kurz and J. D. Erusalimsky
Research Letter: Role of Telomerase in Human Endothelial Cell Proliferation
Arterioscler Thromb Vasc Biol, November 1, 2003; 23(11): e54 - 54.
[Full Text]


Home page
J. Histochem. Cytochem.Home page
E. Sadoun and M. J. Reed
Impaired Angiogenesis in Aging Is Associated with Alterations in Vessel Density, Matrix Composition, Inflammatory Response, and Growth Factor Expression
J. Histochem. Cytochem., September 1, 2003; 51(9): 1119 - 1130.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Haendeler, J. Hoffmann, R. P. Brandes, A. M. Zeiher, and S. Dimmeler
Hydrogen Peroxide Triggers Nuclear Export of Telomerase Reverse Transcriptase via Src Kinase Family-Dependent Phosphorylation of Tyrosine 707
Mol. Cell. Biol., July 1, 2003; 23(13): 4598 - 4610.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. M. Dewberry, D. C. Crossman, and S. E. Francis
Interleukin-1 Receptor Antagonist (IL-1RN) Genotype Modulates the Replicative Capacity of Human Endothelial Cells
Circ. Res., June 27, 2003; 92(12): 1285 - 1287.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. Assmus, C. Urbich, A. Aicher, W. K. Hofmann, J. Haendeler, L. Rossig, I. Spyridopoulos, A. M. Zeiher, and S. Dimmeler
HMG-CoA Reductase Inhibitors Reduce Senescence and Increase Proliferation of Endothelial Progenitor Cells via Regulation of Cell Cycle Regulatory Genes
Circ. Res., May 16, 2003; 92(9): 1049 - 1055.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. J. Kurz, Y. Hong, E. Trivier, H.-L. Huang, S. Decary, G. H. Zang, T. F. Luscher, and J. D. Erusalimsky
Fibroblast Growth Factor-2, But Not Vascular Endothelial Growth Factor, Upregulates Telomerase Activity in Human Endothelial Cells
Arterioscler Thromb Vasc Biol, May 1, 2003; 23(5): 748 - 754.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. S. Deshpande, B. Qi, Y. C. Park, and K. Irani
Constitutive Activation of rac1 Results in Mitochondrial Oxidative Stress and Induces Premature Endothelial Cell Senescence
Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): e1 - 6.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Murasawa, J. Llevadot, M. Silver, J. M. Isner, D. W. Losordo, and T. Asahara
Constitutive Human Telomerase Reverse Transcriptase Expression Enhances Regenerative Properties of Endothelial Progenitor Cells
Circulation, August 27, 2002; 106(9): 1133 - 1139.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Chen, S. V. Brodsky, D. M. Goligorsky, D. J. Hampel, H. Li, S. S. Gross, and M. S. Goligorsky
Glycated Collagen I Induces Premature Senescence-Like Phenotypic Changes in Endothelial Cells
Circ. Res., June 28, 2002; 90(12): 1290 - 1298.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
P.M. Vanhoutte
Ageing and endothelial dysfunction
Eur. Heart J. Suppl., February 1, 2002; 4(suppl_A): A8 - A17.
[Abstract] [PDF]


Home page
Circ. Res.Home page
S. J. Zieman, G. Gerstenblith, E. G. Lakatta, G. O. Rosas, K. Vandegaer, K. M. Ricker, and J. M. Hare
Upregulation of the Nitric Oxide-cGMP Pathway in Aged Myocardium : Physiological Response to l-Arginine
Circ. Res., January 19, 2001; 88(1): 97 - 102.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Hoffmann, J. Haendeler, A. Aicher, L. Rossig, M. Vasa, A. M. Zeiher, and S. Dimmeler
Aging Enhances the Sensitivity of Endothelial Cells Toward Apoptotic Stimuli: Important Role of Nitric Oxide
Circ. Res., October 12, 2001; 89(8): 709 - 715.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Matsushita, E. Chang, A. J. Glassford, J. P. Cooke, C.-P. Chiu, and P. S. Tsao
eNOS Activity Is Reduced in Senescent Human Endothelial Cells: Preservation by hTERT Immortalization
Circ. Res., October 26, 2001; 89(9): 793 - 798.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vasa, M.
Right arrow Articles by Dimmeler, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vasa, M.
Right arrow Articles by Dimmeler, S.